Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III, a Prospective Phase II Treatment Trial

NCT05076942 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05076942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05076942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III, a Prospective Phase II Treatment Trial
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2021
Completion date
January 1, 2029
Enrollment
157 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastases, sentinel lymph node, vulvar cancer